Application of Arsenic Trioxide-Based Combined Sequential Chemotherapy in Recurrent Resistant and Refractory Ovarian Cancers: A Single-Center, Open Phase II Clinical Study

OBJECTIVE: Arsenic trioxide (ATO) has been effectively used for the treatment of hematological malignancies and some solid tumors, while ATO effects were not tested clinically in epithelial ovarian cancer (EOC). METHODS: Patients with primary or secondary platinum-resistant EOC were enrolled from Oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yingchao, Li, Xiaoping, Wang, Yue, Shen, Xiaoyan, Zhao, Lijun, Wu, Yan, Li, Yi, Wang, Jianliu, Wei, Lihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452931/
https://www.ncbi.nlm.nih.gov/pubmed/36090905
http://dx.doi.org/10.1155/2022/6243165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452931/
https://www.ncbi.nlm.nih.gov/pubmed/36090905
http://dx.doi.org/10.1155/2022/6243165

Ejemplares similares